Left ventricular mass index measured by quantitative gated myocardial SPECT with 99mTc-tetrofosmin: A comparison with echocardiography

Annals of Nuclear Medicine

Volumn 17, Issue 1, 2003, Pages 31-39

  Maruyama, Kaoru ^a   Hasegawa, Shinji ^a   Nakatani, Daisaku ^a   Paul, Asit Kr ^a   Kusuoka, Hideo ^b   Nishimura, Tsunehiko ^c   Hori, Masatsugu ^a   Hatazawa, Jun ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA NATIONAL HOSPITAL   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

99mTc tetrofosmin; Left ventricular mass; M mode echocardiography; Perfusion; Quantitative gated myocardial SPECT

Indexed keywords

TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; BODY SURFACE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ENDOCARDIUM; EPICARDIUM; FEMALE; HEART DISEASE; HEART INFARCTION; HEART LEFT VENTRICLE MASS; HEART PERFUSION; HEART SCINTISCANNING; HEART VOLUME; HUMAN; INTERMETHOD COMPARISON; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0037308277     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02988256     Document Type: Article

References (39)

1. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105:173-178.
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
3. Sullivan JM, Vander Zwaag RV, el-Zeky F, Ramanathan KB, Mirvis DM. Left ventricular hypertrophy: effect on survival. J Am Coll Cardiol 1993; 22: 508-513.
4. Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 1998; 32: 1454-1459.
5. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Inter Med 1969; 71: 89-105.
6. Kannel WB, Gordon T, Castelli WP, Margolis JR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann Intern Med 1970; 72 (6): 813-822.
7. Hall SA, Cigarroa CG, Marcoux L, Risser RC, Grayburn PA, Eichhorn EJ. Time course of improved in left ventricular function, mass, geometry in patients with congestive heart failure with beta-adrenergic blockade. J Am Coll Cardiol 1995; 25: 1154-1161.
8. The SOLVD investigators. Studies of left ventricular dysfunction (SOLVD) rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction. Am J Cardiol 1990; 66 (3): 315-322.
9. Skioldebrand CG, Lipton MJ, Mavroudis C, Hayashi TT. Determination of left ventricular mass by computed tomography. Am J Cardiol 1982; 49: 63-70.
10. Peck WW, Mancini GBJ, Slutsky RA, Mattrey RF, Higgins CB. In vivo assessment by computed tomography of the natural progression of infarct size, left ventricular mass, and function after myocardial infarction in the dog. Am J Cardiol 1984; 53: 929-935.
11. Feiring AJ, Rumberger JA, Reiter SJ, Skorton DJ, Collins SM, Lipton MJ, et al. Determination of left ventricular mass in dogs with rapid-acquisition cardiac computed tomographic scanning. Circulation 1985; 72 (6): 1355-1364.
12. Bexley WA, Dodge HT, Sandler H. A quantitative angiocardiograhic study of left ventricular hypertrophy and the electrocardiogram. Circulation 1968; 37: 509-517.
13. Levy D, Labib SB, Anderson KM, Christiansen JC, Kannel WB, Castelli WP. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 1990; 81 (3): 815-820.
14. Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham TP Jr. Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiov Magn Res 1999; 1: 7-21.
15. Schalla S, Nagel E, Lehmkuhl H, Klein C, Bornstedt A, Schnackenburg B, et al. Comparison of magnetic resonance real-time imaging of left ventricular function with conventional magnetic resonance image and echocardiography. Am J Cardiol 2001; 87: 95-99.
16. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995; 36: 2138-2147.
17. Germano G, Kavanagh PB, Kavanagh JT, Wishner SH, Berman DS, Kavanagh GJ. Repeatability of automatic left ventricular cavity volume measurements from myocardial perfusion SPECT. J Nucl Cardiol 1998; 5: 477-483.
18. 99mTc-tetrofosmin myocardial SPECT. J Nucl Med 1999; 40: 1693-1698.
19. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-618.
20. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
21. Keyes JW Jr, Brady TJ, Leonard PF, Svetkoff DB, Winter SM, Rogers WL, et al. Calculation of viable and infarcted myocardial mass from thallium-201 tomograms. J Nucl Med 1981; 22: 339-343.
22. Holman BL, Moore SC, Shulkin PM, Kirsch CM, English RJ, Hill TC. Quantitation of perfused myocardial mass using T-201 and emission computed tomography. Invest Radiol 1983; 18: 322-326.
23. Wolfe CL, Corbett JR, Lewis SE, Buja LM, Willerson JT. Determination of left ventricular mass by single-photon emission computed tomography. Am J Cardiol 1984; 53: 1365-1368.
24. Narahara KA, Thompson CJ, Maublant JC, Criley JM, Mena I. Estimation of left ventricular mass in normal and infarct canine hearts using thallium-201 SPECT. J Nucl Med 1987; 28: 1315-1321.
25. Wolfe CL, Jansen DE, Corbett JR, Lipscomb K, Gabliani G, Filipchuk N, et al. Determination of left ventricular mass using single-photon emission computed tomography. Am J Cardiol 1985; 56: 761-764.
26. Narahara KA, Thompson CJ, Maublant JC, Brizendine M, Mena I. Thallium-201 single-photon emission computed tomographic estimates of left ventricular mass in patients with and without ischemic heart disease. Am Heart J 1987; 114: 84-90.
27. 201T1 SPECT. Eur J Nucl Med 1987; 13: 446-449.
28. Narahara KA, Villanueva-Meyer J, Thompson CJ, Brizendine M, Mena I. Comparison of thallium-201 and technetium-99m hexakis 2-methoxyisobutyl isonitrile single-photon emission computed tomography for estimating the extent of myocardial ischemia and infarction in coronary artery disease. Am J Cardiol 1990; 66: 1438-1444.
29. Wolfe CL, O'Connell JW, Sievers RE, Cobb C, Dae MW, Botvinick E. Assessment of perfused left ventricular mass in normal, ischemic, and reperfused myocardium by means of single-photon emission computed tomography of technetium-99m isonitrile. Am Heart J 1993; 126; 1275-1286.
30. Leon AR, Eisner RL, Martin SE, Schmarkey LS, Aaron AM, Boyers AS, et al. Comparison of single-photon emission computed tomographic (SPECT) myocardial perfusion imaging with thallium-201 and technetium-99m sestamibi in dogs. J Am Coll Cardiol 1992; 20: 1612-1625.
31. Williams KA, Lang RM, Reba RC, Taillon LA. Comparison of technetium-99m sestamibi-gated tomographic perfusion imaging with echocardiography and electrocardiography for determination of left ventricular mass. Am J Cardiol 1996; 77: 750-755.
32. Germano G, Erel J, Lewin H, Kavanagh PB, Berman DS. Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography J Am Coil J Am Coll Cardiol 1997; 30: 1360-1367.
33. Germano G, Berman DS. On the accuracy and reproducibility of quantitative gated myocardial perfusion SPECT. J Nucl Med 1999; 40: 810-813.
34. Reiner L, Mazzoleni A, Rodriguez FL, Freudenthal RR. The weight of the human heart. Arch Pathol 1959; 68: 58-73.
35. Fujita T. Human Anatomy. Nankoudou 1993; 41: 304-305.
36. Bove KE, Rowlands DT, Scott RC. Observations on the assessment of cardiac hypertrophy utilizing a chamber partition technique. Circulation 1966; 33: 558-568.
37. Nakajima K, Taki J, Higuchi T, Kawano M, Taniguchi M, Maruhashi K, et al. Gated SPET quantification of small hearts: mathematical simulation and clinical application. Eur J Nucl Med 2000; 27: 1372-1379.
38. Toba M, Kumita S, Cho K, Mizumura S, Kijima T, Nakano H, Kumazaki T. Comparison of Emory and Cedars-Sinai methods for assessment of left ventricular function from gated myocardial perfusion SPECT in patients with a small heart. Ann Nucl Med 2000; 14 (6): 421-426.
39. Matsumoto N, Berman DS, Kavanagh PB, Gerlach J, Hayes SW, Lewin HC, et al. Quantitative assessment of motion artifacts and validation of a new motion-correction program for myocardial perfusion SPECT. J Nucl Med 2001; 42: 687-694.